Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”
Author(s) -
Jonathan P. Piccini,
Susanna R. Stevens,
Yuchiao Chang,
Daniel E. Singer,
Yuliya Lokhnygina,
Alan S. Go,
Manesh R. Patel,
Kenneth W. Mahaffey,
Jonathan L. Halperin,
Günter Breithardt,
Graeme J. Hankey,
Werner Hacke,
Richard C. Becker,
Christopher C. Nessel,
Keith A.A. Fox,
Robert M. Califf
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.113.004013
Subject(s) - medicine , atrial fibrillation , stroke (engine) , cardiology , embolic stroke , embolism , ischemic stroke , ischemia , mechanical engineering , engineering
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom